Viridian Therapeutics, Inc.\DE (VRDN) › Total LiabilitiesViridian Therapeutics, Inc.\DE (VRDN) — Total LiabilitiesAnnual figures by fiscal year, from SEC filings.2016: $9.71M2017: $13.97M2018: $14.80M2019: $14.51M2020: $11.22M2021: $15.99M2022: $40.03M2023: $48.40M2024: $70.76M2025: $177.25M$177.25M2016Total Liabilities (USD)2025Fiscal YearTotal LiabilitiesChange YoY2025$177.25M+150.5%2024$70.76M+46.2%2023$48.40M+20.9%2022$40.03M+150.3%2021$15.99M+42.6%2020$11.22M-22.7%2019$14.51M-2.0%2018$14.80M+6.0%2017$13.97M+44.0%2016$9.71M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share